Palo Alto Networks Inc vs Revvity Inc — how do they compare? Palo Alto Networks Inc trades at $335.38 (market cap $278.85B), while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Palo Alto Networks Inc is far larger — about 22.6× Revvity Inc's market cap, and Revvity Inc pays a 0.25% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.
| PANW | RVTY | |
|---|---|---|
Market Cap | $278.85B | $12.33B |
Sector | Technology | Technology |
52-Week High | $358.68 | $117.75 |
52-Week Low | $141.67 | $82.26 |
Enterprise Value | $277.81B | $14.82B |
Dividend Yield | — | 0.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Trailing returns across standard periods
Latest headlines on both assets
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →